Literature DB >> 23832998

Acute lymphocitic leukaemia and AIDS.

Marcelo Rodrigues Bacci1, Janaina Aparecida Boide Santos, Natalia C P Zing, Danielle M Barros.   

Abstract

Patients with AIDS have become more and more prevalent. Therefore, the onset of diseases that coexist with this condition must be studied in order to establish proper diagnosis and treatment. We report a case of a patient who reported with loss of strength in the lower limbs and a progressive worsening in his clinical picture. He was diagnosed with acute lymphocytic leukaemia, an unusual form of association with the AIDS condition. Despite the diagnosis, he evolved into pulmonary sepsis and so staging and chemotherapy treatment could not be performed.

Entities:  

Mesh:

Year:  2013        PMID: 23832998      PMCID: PMC3736233          DOI: 10.1136/bcr-2013-010036

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  The molecular basis of T cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Adolfo Ferrando
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

2.  Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets.

Authors:  Eric J Foss; Dragan Radulovic; Derek L Stirewalt; Jerald Radich; Olga Sala-Torra; Era L Pogosova-Agadjanyan; Shawna M Hengel; Keith R Loeb; H Joachim Deeg; Soheil Meshinchi; David R Goodlett; Antonio Bedalov
Journal:  J Proteome Res       Date:  2012-09-11       Impact factor: 4.466

Review 3.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

Review 4.  Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.

Authors:  Debora Lorenzon; Tiziana Perin; Pietro Bulian; Valli De Re; Laura Caggiari; Mariagrazia Michieli; Rosa Manuele; Michele Spina; Valter Gattei; Marco Fasan; Umberto Tirelli; Vincenzo Canzonieri
Journal:  Hum Pathol       Date:  2009-05-07       Impact factor: 3.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.